Cannara Biotech Inc.

TSXV:LOVE.V

Sector

🛒 Consumer Staples

Industries

🌾 Agriculture

🧬 Biotechnology

🏬 Consumer Packaged Goods

🛍 E-commerce

🛍 Retail & Wholesale

Location

Canada

Market Cap

USD 126.32 M

Share Price

USD 1.38

Avg Daily Volume

90,104

Change (1 day)

1.04%

Change (1 year)

Change (YTD)

141.15%

Cannara Biotech Inc. Accounts Payable for the year ending August 31, 2020: USD 2.11 M

Cannara Biotech Inc. Accounts Payable is USD 2.11 M for the year ending August 31, 2020. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.

Competitors

Sanofi

USD 99.43

SAN.PA

+2.12 2.18%

GSK plc

USD 18.80

GSK.L

-0.55 -2.85%

Zoetis Inc.

USD 154.11

ZTS

+1.05 0.69%

ITC Limited

USD 4.69

ITC.NS

-0.04 -0.91%

Corteva, Inc.

USD 71.76

CTVA

-0.11 -0.15%

Bayer AG

USD 31.66

BAYN.DE

+0.64 2.07%

Novozymes A/S

USD 64.92

NSIS-B.CO

-0.12 -0.19%

Archer-Daniels-Midland Company

USD 59.75

ADM

+0.43 0.73%

DSM-Firmenich AG

USD 96.99

DSFIR.AS

+1.07 1.12%

Yihai Kerry Arawana Holdings Co., Ltd

USD 4.44

300999.SZ

+0.03 0.59%

Wilmar International Limited

USD 2.27

F34.SI

+0.01 0.47%

Alexandria Real Estate Equities, Inc.

USD 76.09

ARE

+1.58 2.12%

Henan Shuanghui Investment & Development Co.,Ltd.

USD 3.51

000895.SZ

+0.00 0.04%

Zydus Lifesciences Limited

USD 11.27

ZYDUSLIFE.NS

-0.03 -0.25%

Pilgrim's Pride Corporation

USD 47.97

PPC

+0.21 0.44%

View all

Key Data

Date	Accounts Payable	Short-Term Debt	Long-Term Debt	Total Liabilities